Skip to main content
Equibles
RGEN logo

RGEN · Repligen Corp · Metrics

Track RGEN — free

Use RGEN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$165.05 -3.48 (-2.06%)
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$9.46B
Shares
56.44M

RGEN metrics

90 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$168.53
Market cap
$9.46B

Price action

20 metrics
Price change (1W)
-4.9%
Price change (30D)
+2.7%
Price change (3M)
+37.0%
Price change (6M)
+39.7%
Price change (YTD)
+2.3%
Price change (1Y)
+39.0%
Trailing year
Price change (5Y)
-42.7%
52-week high
$182.03
52-week low
$102.87
Change from 52-week high
-7.9%
Change from 52-week low
+62.9%
Annualized volatility
46.2%
Annualized volatility (3M)
49.9%
Beta
1.2
RSI (14D)
50.4
Price vs SMA 50
+7.7%
Price vs SMA 200
+18.0%
Avg volume (3M)
1.12M
Relative volume
0.7
Average dollar volume
$167.05M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
56.44M

Valuation

12 metrics
P / E (TTM)
226.5
Trailing earnings · reciprocal yield 0.4%
PEG ratio
—
EV / revenue
11.7×
reciprocal yield 8.5%
EV / EBITDA
64.2×
reciprocal yield 1.6%
EV / EBIT
142.4×
reciprocal yield 0.7%
P / sales
12.0×
reciprocal yield 8.3%
P / book
4.5
reciprocal yield 22.3%
FCF yield
1.2%
TTM · current market cap
Buyback yield
—
P / FCF
84.5
reciprocal yield 1.2%
P / operating cash flow
70.1
reciprocal yield 1.4%
Earnings yield
0.4%

Historical valuation

8 metrics
P / E historical average (3Y)
2,269.6×
reciprocal yield 0.0%
P / E historical average (5Y)
1,368.3×
reciprocal yield 0.1%
EV / revenue historical average (3Y)
10.0×
reciprocal yield 10.0%
EV / revenue historical average (5Y)
10.0×
reciprocal yield 10.0%
EV / EBIT historical average (3Y)
2,614.6×
reciprocal yield 0.0%
EV / EBIT historical average (5Y)
2,614.6×
reciprocal yield 0.0%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
52.3%
Operating margin
8.2%
Trailing 12 months
Net margin
5.3%
Gross profit (TTM)
$209.63M
Operating profit (TTM)
$64.61M
Net income (TTM)
$41.54M
Trailing 12 months
Diluted EPS (TTM)
$0.74
FCF margin
14.3%
Effective tax rate
20.3%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+11.9%
Year over year
Net income growth YoY
-66.3%
Revenue (TTM)
$785.10M
Trailing 12 months
EPS growth YoY
-65.4%
Shares change YoY
+0.2%
Year over year · more shares
Revenue CAGR (3Y)
-2.7%
Revenue CAGR (5Y)
+15.0%
EPS CAGR (3Y)
-35.7%
EPS CAGR (5Y)
-5.0%
FCF CAGR (3Y)
+2.5%
FCF CAGR (5Y)
+18.5%

Quality

14 metrics
Return on equity
2.0%
Return on assets
1.4%
Debt / equity
0.3
Current ratio
9.1
EBITDA (TTM)
$143.39M
Free cash flow (TTM)
$111.97M
Quick ratio
7.6
Interest coverage
2.9
Net debt / EBITDA
-1.8
Return on invested capital
2.8%
Trailing 12 months
Net cash
$259.40M
Latest balance sheet
Cash & equivalents
$606.78M
Total assets
$2.95B
Total debt
$551.05M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$134.86M
Capital expenditures (TTM)
$22.90M
R&D (TTM)
$56.97M
SG&A (TTM)
$302.05M
Stock compensation (TTM)
$33.29M
R&D / revenue
7.3%
Stock compensation / revenue
4.2%

Ownership (13F)

3 metrics
13F filers
487
13F filer change QoQ
+39
Institutional ownership
118.4%

Short interest

3 metrics
Short interest
10.8%
Latest settlement · 6.4 days to cover
Days to cover
6.4d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.67M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 730272 CUSIP 759916109 13F (30d) 277 filings 275 filers Visit website Investor relations